Dr.Guido, the pioneering startup in the field of digital health, is spearheading a revolution in the global healthcare sector with its innovative AI-driven platform. The significance of Dr.Guido lies in its mission to make healthcare accessible to all, including countries with a scarcity of doctors, revolutionizing how people interact with medical care.

Dr.Guido's distinctive approach focuses on empathy between patients and the AI Doctor, redefining the concept of personalized and accessible healthcare. Unlike competing with doctors, Dr.Guido provides an AI-driven pre-diagnosis, which patients can share with physicians to expedite the understanding of medical conditions.

It is important to emphasize that, despite its ability to offer a preliminary assessment, Dr.Guido always advises patients to consult a specialist for an accurate diagnosis and appropriate treatment.

Dr.Guido's mobile app offers a range of innovative services, including Second Opinion and SmartScan Med. These tools allow patients to obtain a second opinion on diagnoses and treatments, as well as detailed information on medications through a simple scan.

Currently operational in Milan, Dr.Guido is now raising funds for an aggressive international expansion strategy. In the meantime, the website offers users the opportunity to test the empathic interaction with the AI Doctor without the need for registration.

Milan, Italy - February 16, 2023 - DrGuido.ai, the innovative AI-driven healthcare startup, concluded its first public presentation at the AI*Festival in Milan on February 15th. The two-day event witnessed overwhelming interest and curiosity from the audience regarding the AI Doctor mobile app. With over 250 inquiries and 150 AI Doctor tests conducted on the website www.drguido.ai, the response was beyond expectations.

Most attendees were drawn to the first B2C application of generative artificial intelligence. Many questions revolved around privacy and how the medical sector would perceive this type of innovation. In summary, the event gathered many confirmations of the strategic key points presented by the mobile app: 1) native Zero Party Data in terms of privacy, 2) central focus on empathy rather than medical knowledge, 3) not a healthcare support but a tool for engaging with consumers on healthcare topics, 4) tool for summarizing requests to forward to healthcare professionals, where DrGuido offers the option to send a summary to the primary care physician at the end of the user interaction, 5) focus on Pre-Diagnosis results rather than diagnosis, with Pre-Diagnosis representing a hypothesis of identified problems based on provided information, 6) in every Pre-Diagnosis, DrGuido always suggests contacting a doctor or specialist for a diagnosis and potential prescription of medication or treatment, 7) proposed price of the premium version €4.97, accessible and excellent for services offered, such as SecondOpinion, which, by uploading a document like an analysis or diagnosis, produces a detailed description always with an empathetic tone towards the individual user. SmartScan, which, with a photo of a medication, provides a comprehensive and empathetic description of the medication, indicating its purpose, how to use it, and any contraindications.

In conclusion, DrGuido is not a medical or telemedicine support but an empathetic response tool to user questions. The event audience strongly affirmed that DrGuido represents an initial demonstration of how Generative Artificial Intelligence can be a tool that will benefit people of all ages, rather than posing a danger to humanity. There were also many proposals for collaboration and partnerships, including potential investors interested in DrGuido as a tool for countries in the developing world, where access to medical services is almost nonexistent. In short, all the conditions are in place for a great success and a case of a highly successful startup at the international level.

DrGuido, the revolutionary startup in AI-based healthcare, is pleased to announce its participation in the highly anticipated World AI Cannes Festival (WAICF), scheduled from February 8th to February 10th, 2024, in Cannes.

WAICF is one of the most prestigious international events dedicated to AI, bringing together experts, innovators, and industry leaders to explore the challenges and opportunities of artificial intelligence. This event provides an ideal platform for DrGuido to showcase the progress of its innovative AI Doctor App in the field of healthcare.

The DrGuido team will be available to discuss potential collaboration, partnerships, and investment opportunities with companies and professionals interested in transforming healthcare through technology.

We look forward to meeting you at the AI Conference in Cannes on 02/08/2024 and sharing DrGuido's vision for a more accessible and empathetic future in healthcare.

For more information or to schedule a meeting, please contact us

The mission of DrGuido.ai is to transform the digital health sector through the pioneering use of generative artificial intelligence. Our AI-driven mobile app focuses on providing pre-diagnosis services, offering users quick and personalized access to health evaluations based on advanced data. "We aim to be leaders in the use of generative AI for digital health, offering a B2C solution that is already redefining the way people access medical care" says Gabriele Taviani, Founder and Business Advisor of DrGuido.ai.

One of the main driving forces of DrGuido.ai is the commitment to protecting users' personal data. The startup operates in full compliance with recent privacy regulations, including careful adherence to the European Community's AiAct. This approach ensures not only technological excellence but also maximum security and respect for user privacy.

In addition, DrGuido.ai stands out for its unique organizational structure, with a board composed of young university students and recent graduates, who bring freshness, innovation, and a cutting-edge perspective. This choice reflects the startup's commitment to promoting new talents and revolutionary ideas in the field of healthcare technology.

The Ai*Festival event will be an unmissable opportunity to get a close look at DrGuido.ai and its innovations in the field of digital health. We invite investors, industry experts, and media to join us in discovering the future of AI-assisted pre-diagnosis and to seize the opportunity to invest in one of the most promising startups in the field of generative artificial intelligence.